These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1359 related items for PubMed ID: 27669504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI, Harari PM, Giralt J, Bell D, Raben D, Liu J, Schulten J, Ang KK, Bonner JA.
    J Clin Oncol; 2016 Apr 20; 34(12):1300-8. PubMed ID: 26712222
    [Abstract] [Full Text] [Related]

  • 7. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Frakes JM, Naghavi AO, Demetriou SK, Strom TJ, Russell JS, Kish JA, McCaffrey JC, Otto KJ, Padhya TA, Harrison LB, Trotti AM, Caudell JJ.
    Cancer; 2016 Feb 15; 122(4):634-41. PubMed ID: 26565997
    [Abstract] [Full Text] [Related]

  • 8. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.
    Koutcher L, Sherman E, Fury M, Wolden S, Zhang Z, Mo Q, Stewart L, Schupak K, Gelblum D, Wong R, Kraus D, Shah J, Zelefsky M, Pfister D, Lee N.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):915-22. PubMed ID: 20947269
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Zimrin A, Strome S, Regine W, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1823-30. PubMed ID: 21549516
    [Abstract] [Full Text] [Related]

  • 12. Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study.
    Hall SF, Liu FF, O'Sullivan B, Shi W, Rohland S, Griffiths R, Groome P.
    Br J Cancer; 2017 Oct 10; 117(8):1105-1112. PubMed ID: 28829763
    [Abstract] [Full Text] [Related]

  • 13. Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.
    Corry J, Bressel M, Fua T, Herschtal A, Solomon B, Porceddu SV, Wratten C, Rischin D.
    Int J Radiat Oncol Biol Phys; 2017 Jul 15; 98(4):948-954. PubMed ID: 28483336
    [Abstract] [Full Text] [Related]

  • 14. Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
    Ou D, Levy A, Blanchard P, Nguyen F, Garberis I, Casiraghi O, Scoazec JY, Janot F, Temam S, Deutsch E, Tao Y.
    Oral Oncol; 2016 Aug 15; 59():50-57. PubMed ID: 27424182
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
    Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Jordan RCK, Zhao W, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT.
    Lancet; 2019 Jan 05; 393(10166):40-50. PubMed ID: 30449625
    [Abstract] [Full Text] [Related]

  • 17. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA.
    Cancer; 2017 Jul 15; 123(14):2762-2772. PubMed ID: 28323338
    [Abstract] [Full Text] [Related]

  • 18. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS, Kim S, David JM, Yoshida EJ, Tighiouart M, Shiao SL, Scher K, Mita A, Sherman EJ, Lee NY, Ho AS.
    Cancer; 2017 May 01; 123(9):1555-1565. PubMed ID: 28001302
    [Abstract] [Full Text] [Related]

  • 19. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
    Al-Saleh K, El-Sherify M, Safwat R, Elbasmy A, Shete J, Hussein A, Nazeeh M, Bedair A.
    Gulf J Oncolog; 2019 May 01; 1(30):6-12. PubMed ID: 31242976
    [Abstract] [Full Text] [Related]

  • 20. Human papillomavirus-associated squamous cell carcinoma of the upper aerodigestive tract.
    Stelow EB, Jo VY, Stoler MH, Mills SE.
    Am J Surg Pathol; 2010 Jul 01; 34(7):e15-24. PubMed ID: 20534998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.